Metformin activates p53 via ribosomal stress in A549 lung cancer cells
碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 100 === Epidemic studies provide evidences that use of metformin, a drug most widely treated for typeⅡ diabetes, is associated with obvious reduction in cancer risk. In a previous study, we showed that metformin inhibited (A549) lung cancer cancer cells and induced...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/38406131452159463115 |